C. Vorsatz

CMV and HSV-2 myeloradiculitis in an HIV infected patient.

S. W. Cardoso, M. Lima, Rodrigo Escada, 2011, Revista do Instituto de Medicina Tropical de Sao Paulo.

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.

C. Delaugerre, C. Fagard, V. Veloso, 2014, The Lancet. Infectious diseases.

HIV Controllers With Different Viral Load Cutoff Levels Have Distinct Virologic and Immunologic Profiles

M. Stevenson, V. Veloso, B. Grinsztejn, 2015, Journal of acquired immune deficiency syndromes.

Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects.

V. Veloso, B. Grinsztejn, G. Bello, 2013, Vaccine.

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.

C. Delaugerre, C. Fagard, V. Veloso, 2014, The Lancet. Infectious diseases.